Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Topics - Biologics, Proteins, Vaccines


Refine by Date:
From: To:
By Kevin O'Donnell
Published January 23, 2012
New questions about maintaining drug quality Read More »
By Gil Roth
Published January 18, 2012
Baltimore CMO awarded $15 mil-plus development, manufacturing deal Read More »
By Gil Roth
Published January 11, 2012
Will provide clinical materials, support to ImmusanT Read More »
By Gil Roth
Published January 10, 2012
Research, diagnostics pact hinges on expression platform license Read More »
By Gil Roth
Published January 9, 2012
PE owners sell for $350 million Read More »
By Gil Roth
Published January 4, 2012
Covers cell line engineering and manufacturing Read More »
By Gil Roth
Published December 27, 2011
IL-17 deal could top $200 million before royalties Read More »
By Gil Roth
Published December 22, 2011
Baxter to pay $33 million upfront in six-drug biosimilars pact Read More »
By Gil Roth
Published December 20, 2011
Companies to pursue onco-antibodies worldwide Read More »
By Gil Roth
Published December 19, 2011
Realtime analytical systems to complement microbiology offerings. Read More »
By Gil Roth
Published December 16, 2011
Sharer, Perlmutter to hand reins to Bradway, Harper in 2012 Read More »
By Gil Roth
Published December 15, 2011
Moves HQ to NJ, boosts R&D in MA Read More »
By Lee Karras
Published December 14, 2011
Acquired by PE firms, the CRO looks to the future Read More »
By Gil Roth
Published December 14, 2011
To develop biomanufacturing facilities in emerging markets Read More »
By Gil Roth
Published December 13, 2011
Zhang joins GMP team Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On